Unique ID issued by UMIN | UMIN000041018 |
---|---|
Receipt number | R000046842 |
Scientific Title | Randomised, parallel-group study to compare the efficacy of coconut oil versus potassium permanganate for the treatment of tungiasis in children in Homa Bay County, Kenya |
Date of disclosure of the study information | 2020/07/10 |
Last modified on | 2024/01/09 12:54:14 |
Comparative study on coconut oil versus potassium permanganate for the treatment of tungiasis in children in Homa Bay County, Kenya
Comparison of coconut oil versus potassium permanganate for tungiasis in Kenya
Randomised, parallel-group study to compare the efficacy of coconut oil versus potassium permanganate for the treatment of tungiasis in children in Homa Bay County, Kenya
Randomised, clinical study to compare coconut oil versus potassium permanganate for tungiasis in children in Kenya
Africa |
tungiasis
Dermatology | Child |
Others
NO
To determine if coconut oil is superior to KMnO4 solution for topical treatments for tungiasis in school-age children in Homa Bay, Kenya
To assess the safety of coconut oil and KMnO4 solution in children with tungiasis
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Treatment-induced change (improvement or deterioration) in the skin condition affected by tungiasis within 2 weeks
Development of adverse events/effects and symptomatic improvements within 2 weeks
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Coconut oil for the fist 3 days
0.05% potassium permanganate (KMnO4) solution, only once at the beginning
8 | years-old | <= |
14 | years-old | >= |
Male and Female
Children with an established diagnosis of tungiasis with stage II or IIIa based on rapid assessment by Fortaleza classification, which describes flea viability signs such as pulsation of the abdomen, expulsion of eggs, and excretion of a faecal thread.
Children with severe tungiasis including those with infestation with 10 or more fleas, and any disability preventing active cooperation in the study and those who have received treatment four weeks before the intervention and allergic to any of the treatments studied will be excluded. The severe cases will be referred to the Subcounty hospital for further clinical treatment.
240
1st name | Yasuhiko |
Middle name | |
Last name | Kamiya |
Nagasaki University
School of Tropical Medicine & Global Health
852-8523
1-12-4 Sakamoto, Nagasaki
81958197891
ykami@nagasaki-u.ac.jp
1st name | Yasuhiko |
Middle name | |
Last name | Kamiya |
Nagasaki University
School of Tropical Medicine & Global Health
852-8523
1-12-4 Sakamoto, Nagasaki
81958197891
ykami@nagasaki-u.ac.jp
Nagasaki University
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Japan
Nagasaki University School of Tropical Medicine & Global Health Ethics Committee
1-12-4 Sakamoto, Nagasaki
81958197583
tmgh_jimu@ml.nagasaki-u.ac.jp
NO
2020 | Year | 07 | Month | 10 | Day |
not yet
Unpublished
not yet
0
The clinical trial has not yet conducted
2023 | Year | 01 | Month | 07 | Day |
Delay expected |
due to COVID-19 pandemic
not yet determined
not yet determined
not yet occurred
not yet conducted
Preinitiation
2020 | Year | 07 | Month | 05 | Day |
2020 | Year | 12 | Month | 24 | Day |
2024 | Year | 02 | Month | 25 | Day |
2024 | Year | 04 | Month | 25 | Day |
2020 | Year | 07 | Month | 06 | Day |
2024 | Year | 01 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046842
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |